These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32922082)

  • 1. Aberrant Expression of NCAPG is Associated with Prognosis and Progression of Gastric Cancer.
    Sun DP; Lin CC; Hung ST; Kuang YY; Hseu YC; Fang CL; Lin KY
    Cancer Manag Res; 2020; 12():7837-7846. PubMed ID: 32922082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCAPG deregulation indicates poor patient survival and contributes to colorectal carcinogenesis.
    Sun DP; Wu CC; Chou CL; Cheng LC; Wang WC; Lin SS; Hung ST; Tian YF; Fang CL; Lin KY
    Pathol Res Pract; 2023 Jan; 241():154238. PubMed ID: 36442414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer.
    Zheng T; Qian T; Zhou H; Cheng Z; Liu G; Huang C; Dou R; Liu F; You X
    Aging (Albany NY); 2023 Jun; 15(12):5535-5549. PubMed ID: 37335105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition by activating the Wnt/β-catenin signaling pathway.
    Shi Y; Ge C; Fang D; Wei W; Li L; Wei Q; Yu H
    Cancer Cell Int; 2022 Mar; 22(1):119. PubMed ID: 35292013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma.
    Guo ZY; Zhu ZT
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7238-7251. PubMed ID: 34919223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonstructural maintenance of chromatin condensin I complex subunit G promotes the progression of glioblastoma by facilitating Poly (ADP-ribose) polymerase 1-mediated E2F1 transactivation.
    Hou J; Huang P; Xu M; Wang H; Shao Y; Weng X; Liu Y; Chang H; Zhang L; Cui H
    Neuro Oncol; 2023 Nov; 25(11):2015-2027. PubMed ID: 37422706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
    Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J
    Gene; 2021 Jan; 766():145163. PubMed ID: 32980450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma.
    Liu W; Liang B; Liu H; Huang Y; Yin X; Zhou F; Yu X; Feng Q; Li E; Zou Z; Wu L
    Int J Mol Med; 2017 Sep; 40(3):731-738. PubMed ID: 28737823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway.
    Wu Y; Lin Y; Pan J; Tu X; Xu Y; Li H; Chen Y
    Cancer Cell Int; 2021 Aug; 21(1):443. PubMed ID: 34419073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.
    Zhang Q; Su R; Shan C; Gao C; Wu P
    Oncol Res; 2018 Mar; 26(2):269-276. PubMed ID: 29046167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRK3 as a Prognosis Biomarker in Gastric Cancer.
    Fang CL; Tian YF; Lin SS; Hung ST; Hseu YC; Chang CC; Chou CL; Chen LC; Wang WC; Lin KY; Sun DP
    J Cancer; 2022; 13(4):1299-1306. PubMed ID: 35281865
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel mechanism driving poor-prognostic gastric cancer: overexpression of the transcription factor Krüppel-like factor 16 promotes growth and metastasis of gastric cancer through regulating the Notch pathway.
    Sun DP; Tian YF; Lin CC; Hung ST; Uen YH; Hseu YC; Chou CL; Cheng LC; Wang WC; Kuang YY; Fang CL; Lin KY
    Am J Cancer Res; 2021; 11(6):2717-2735. PubMed ID: 34249424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCAPG is a prognostic biomarker of immune infiltration in non-small-cell lung cancer.
    Zhou Y; Fan Y; Mao Y; Lou M; Liu X; Yuan K; Tong J
    Biomark Med; 2022 May; 16(7):523-535. PubMed ID: 35199566
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer.
    Xu T; Dong M; Wang Z; Li H; Li X
    Cancer Manag Res; 2020; 12():5773-5786. PubMed ID: 32765080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCAPG as a Novel Prognostic Biomarker in Glioma.
    Jiang X; Shi Y; Chen X; Xu H; Liu B; Zhou F; Huang X; Cho WC; Li L; Pu J
    Front Oncol; 2022; 12():831438. PubMed ID: 35280743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCAPG as a novel prognostic biomarker in numerous cancers: a meta-analysis and bioinformatics analysis.
    Lin J; Li G; Bai Y; Xie Y
    Aging (Albany NY); 2023 Mar; 15(7):2503-2524. PubMed ID: 36996493
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhang X; Wang H; Han Y; Zhu M; Song Z; Zhan D; Jia J
    Onco Targets Ther; 2020; 13():11315-11326. PubMed ID: 33177839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of NCAPG in various of tumors.
    Cai X; Gao J; Shi C; Guo WZ; Guo D; Zhang S
    Biomed Pharmacother; 2022 Nov; 155():113635. PubMed ID: 36095957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
    Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
    World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.